Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02878629

Enrollment

254

Registered

2016-08-25

Start date

2016-07-31

Completion date

2019-08-31

Last updated

2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Syndrome of Obstructive Sleep Apnea and Hypopneas

Brief summary

The main objective is to evaluate middle term compliance (≥ 2 years) of the Mandibular Advancement Devices Tali® in patients with Syndrome of Obstructive Sleep Apnea and Hypopneas.

Interventions

DEVICEMandibular Advancement Devices

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* Patients \> 18 years treated with Mandibular Advancement Device Tali® from at least 2 years and at the latest 5 years. * Patients who agree to participate to the study.

Design outcomes

Primary

Measure	Time frame
compliance (no stop of the Mandibular Advancement Device)	2 years or more after the beginning of device

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026